YOLFTbeta
Tanvex BioPharma Inc

Tanvex BioPharma Inc

6541 · TW · Healthcare / Biotechnology

28.10TWD+0.05 (+0.18%)

Price History

Full chart

Market Stats

Previous Close28.05
Open27.95
Day Range27.50 – 28.60
52-Week Range29.60 – 68.00
Volume402.74K
Market Cap7.84B
P/E (TTM)0.00
Forward P/E0.00
EPS-5.54
Dividend Yield0.00%
Beta0.20
50-Day Avg34.33
200-Day Avg41.95

About

Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Stephen Lam
  • Employees215
  • Headquarters802 West Bay Road, George Town, Cayman Islands, KY1-1205, Taiwan
  • Websitehttps://www.tanvex.com

Leadership

  • Mr. Stephen LamCEO & Director
  • Dr. Allen Y. Chao Ph.D.Founder & Honorary Chairman · b. 1946
  • Mr. James WilliamsonChief Accounting Officer
  • Mr. Marc GoemansChief Commercial Officer
  • Mr. John R. MosackChief Operating Officer of US
  • Mr. Miguel CarrionVice President of R&D - USA
  • Ms. Angela LuanCFO & Corporate Governance Officer
  • Val ChenVP of Finance, Director of Operations. Management & Corporate Governance Officer
  • Mr. Zheng XiaChief Technology Officer
  • Linda GrilloDirector of Sales & Marketing

Financials

Income Statement

Currency: TWD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---0000300.00K5.41M22.40M61.41M34.68M400.97M
Growth (%)--------+1702.00%+314.43%+174.11%-43.53%+1056.27%
Cost of Revenue--67.38M117.58M132.71M142.77M215.96M157.00K1.86M41.75M1.71M26.39M841.68M
Gross Profit---67.38M-117.58M-132.71M-142.77M-215.96M143.00K3.55M-19.35M59.70M8.29M-440.71M
Gross Margin-------47.67%65.67%-86.36%97.22%23.91%-109.91%
Operating Expense--764.57M1.23B1.27B1.81B2.04B2.09B1.50B1.57B2.16B1.37B947.48M
Operating Income-301.35M-464.90M-831.95M-1.35B-1.40B-1.95B-2.26B-2.09B-1.50B-1.59B-2.10B-1.36B-1.39B
Operating Margin--------695214.00%-27690.84%-7080.82%-3420.80%-3912.40%-346.21%
EBITDA-275.69M-426.04M-767.85M-1.13B-1.28B-1.75B-2.04B-1.87B-1.25B-1.30B-1.75B-1.04B-1.02B
EBITDA Margin--------621745.00%-23185.07%-5824.08%-2856.91%-2995.62%-254.74%
Net Income-299.03M-472.49M-835.25M-1.24B-1.41B-1.89B-2.27B-2.10B-1.54B-1.64B-2.14B-1.38B-1.50B
Net Income Margin--------701412.00%-28546.26%-7325.17%-3480.00%-3983.94%-374.13%
R&D215.51M340.56M662.20M1.11B1.08B1.65B2.00B1.86B1.38B1.35B1.71B1.06B187.57M
R&D as % of Total Revenue-------620200.00%25592.32%6032.07%2779.21%3052.41%46.78%
Interest Expense-6.25M-00015.58M18.57M46.22M54.72M57.38M53.34M47.23M
Interest Expense % of Total Revenue-------6190.00%855.01%244.24%93.44%153.82%11.78%

Balance Sheet

Currency: TWD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets487.27M654.74M1.57B3.87B3.97B4.48B3.57B4.37B4.71B3.42B2.76B2.74B7.96B
Total Liabilities83.63M65.09M121.41M299.25M223.78M263.92M542.12M1.75B1.92B2.03B1.94B1.84B2.27B
Total Equity403.64M589.64M1.45B3.57B3.75B4.21B3.03B2.62B2.79B1.39B821.11M893.31M5.69B
Cash168.52M203.21M758.23M1.30B2.01B1.63B2.43B2.07B2.22B786.23M380.75M376.96M878.71M
Total Debt384.00K538.00K-1.93M1.40M61.73M342.74M1.52B1.76B1.84B1.73B1.65B1.58B
Net Debt-168.13M-202.67M-758.23M-1.30B-2.01B-1.57B-2.08B-549.19M-463.95M1.05B1.35B1.27B699.69M

Cash Flow

Currency: TWD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-239.86M-434.17M-684.20M-833.43M-1.21B-1.61B-1.90B-1.79B-1.39B-1.33B-1.43B-1.15B-1.01B
Investing Cash Flow-55.60M-153.04M-394.24M-1.86B339.83M-912.44M1.82B-243.30M-24.68M-97.35M-83.57M-109.25M301.80M
Financing Cash Flow469.55M616.96M1.61B3.34B1.66B2.15B914.15M1.73B1.60B-123.29M1.08B1.26B1.14B
Capital Expenditure47.48M156.06M373.47M248.56M116.60M108.76M93.60M67.50M30.35M96.08M71.34M110.77M670.20M
Free Cash Flow-287.33M-590.24M-1.06B-1.08B-1.33B-1.71B-1.99B-1.86B-1.42B-1.43B-1.51B-1.26B-1.68B
FCF to OCF119.79%135.94%154.59%129.82%109.62%106.77%104.93%103.78%102.19%107.20%104.98%109.63%166.66%

Earnings

Report DateNov 17, 2016Dec 31, 2016May 12, 2017Aug 14, 2017Nov 14, 2017Mar 30, 2018May 9, 2018Aug 14, 2018Nov 9, 2018Mar 28, 2019May 13, 2019Aug 13, 2019Nov 13, 2019Mar 27, 2020May 10, 2020Aug 13, 2020Nov 12, 2020Mar 29, 2021May 14, 2021Aug 26, 2021Nov 13, 2021Mar 27, 2022May 13, 2022Aug 26, 2022Nov 14, 2022Mar 3, 2023May 12, 2023Aug 9, 2023Nov 13, 2023
EPS Estimate-------5.28-5.31-5.98-2.48-8.33-8.51-8.48-1.99-6.98-7.13-6.61-6.15-5.55-4.82-4.36-4.74-3.66-2.79-2.85-2.69-2.22-1.90-
EPS Actual-4.34-6.77-5.09-5.07-4.43-5.26-4.56-5.40-6.09-1.43-6.36-6.54-8.45-2.11-6.98-6.36-5.16-4.98-3.94-3.63-3.66-2.91-2.82-1.21-3.45-3.95-5.17-3.82-3.78
Surprise------13.64%-1.69%-1.84%42.34%23.65%23.15%0.35%-6.03%0.00%10.80%21.94%19.02%29.01%24.69%16.05%38.61%22.95%56.55%-21.05%-46.84%-132.88%-101.05%-
TimingPre-market-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap7.84B
Enterprise Value9.82B
Trailing P/E0.00
Forward P/E0.00
Price / Sales11.93
Price / Book1.68
EPS-5.54
Book Value18.74
Revenue (TTM)657.56M
Gross Profit (TTM)-898.48M
EBITDA-1.30B
Profit Margin-222.84%
Operating Margin-166.52%
Return on Equity-29.78%
Return on Assets-12.28%
Shares Outstanding264.99M
Shares Float108.19M
Beta0.20
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 27, 2023703:689
  • Mar 2, 2023456:1367
  • Sep 7, 20215399:5349
  • Nov 25, 2020543:532
  • Nov 4, 20191225:1217
  • Jul 10, 2018553:548
  • Jan 26, 2016809:766